Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance
- PMID: 11872659
- DOI: 10.2337/diabetes.51.3.624
Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance
Abstract
Adipose tissue glyceroneogenesis generates glycerol 3-phosphate, which could be used for fatty acid esterification during starvation. To determine whether increased glyceroneogenesis leads to increased fat mass and to explore the role of obesity in the development of insulin resistance, we overexpressed PEPCK, a regulatory enzyme of glyceroneogenesis in adipose tissue. Transgenic mice showed a chronic increase in PEPCK activity, which led to increased glyceroneogenesis, re-esterification of free fatty acids (FFAs), increased adipocyte size and fat mass, and higher body weight. In spite of increased fat mass, transgenic mice showed decreased circulating FFAs and normal leptin levels. Moreover, glucose tolerance and whole-body insulin sensitivity were preserved. Skeletal muscle basal and insulin-stimulated glucose uptake and glycogen content were not affected, suggesting that skeletal muscle insulin sensitivity is normal in transgenic obese mice. Our results indicate the key role of PEPCK in the control of FFA re-esterification in adipose tissue and, thus, the contribution of glyceroneogenesis to fat accumulation. Moreover, they suggest that higher fat mass without increased circulating FFAs does not lead to insulin resistance or type 2 diabetes in these mice.
Similar articles
-
Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity.Diabetes. 2006 Feb;55(2):273-80. doi: 10.2337/diabetes.55.02.06.db05-0482. Diabetes. 2006. PMID: 16443757
-
Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes.Diabetologia. 2007 Mar;50(3):666-75. doi: 10.1007/s00125-006-0560-5. Epub 2007 Jan 23. Diabetologia. 2007. PMID: 17242918
-
[Glyceroneogenesis and PEPCK-C: pharmacological targets in type 2 diabetes].Med Sci (Paris). 2008 Apr;24(4):407-13. doi: 10.1051/medsci/2008244407. Med Sci (Paris). 2008. PMID: 18405640 Review. French.
-
Proposed involvement of adipocyte glyceroneogenesis and phosphoenolpyruvate carboxykinase in the metabolic syndrome.Biochimie. 2005 Jan;87(1):27-32. doi: 10.1016/j.biochi.2004.12.005. Biochimie. 2005. PMID: 15733733 Review.
-
Glyceroneogenesis revisited.Biochimie. 2003 Dec;85(12):1199-205. doi: 10.1016/j.biochi.2003.10.022. Biochimie. 2003. PMID: 14739071 Review.
Cited by
-
Impaired Remodeling of White Adipose Tissue in Obesity and Aging: From Defective Adipogenesis to Adipose Organ Dysfunction.Cells. 2024 Apr 30;13(9):763. doi: 10.3390/cells13090763. Cells. 2024. PMID: 38727299 Free PMC article. Review.
-
Sex-Dependent Metabolic Effects in Diet-Induced Obese Rats following Intermittent Fasting Compared with Continuous Food Restriction.Nutrients. 2024 Mar 29;16(7):1009. doi: 10.3390/nu16071009. Nutrients. 2024. PMID: 38613042 Free PMC article.
-
The regulation of adipocyte growth in white adipose tissue.Front Cell Dev Biol. 2022 Nov 22;10:1003219. doi: 10.3389/fcell.2022.1003219. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36483678 Free PMC article. Review.
-
Metformin can mitigate skeletal dysplasia caused by Pck2 deficiency.Int J Oral Sci. 2022 Nov 15;14(1):54. doi: 10.1038/s41368-022-00204-1. Int J Oral Sci. 2022. PMID: 36376276 Free PMC article.
-
Potential novel biomarkers in small intestine for obesity/obesity resistance revealed by multi-omics analysis.Lipids Health Dis. 2022 Oct 8;21(1):98. doi: 10.1186/s12944-022-01711-0. Lipids Health Dis. 2022. PMID: 36209126 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases